Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,717	1,997	1,581	1,928	1,551	1,326
Market Cap Growth	26.29%	26.29%	-18.00%	24.34%	16.99%	6.52%
Enterprise Value	1,298	1,632	1,398	1,849	1,128	1,019
Last Close Price	30.76	36.16	28.94	35.67	29.16	25.16
PE Ratio	23.30	27.03	1201.42	31.76	29.03	10.44
Forward PE	15.67	19.65	15.34	30.84	15.73	15.73
PS Ratio	2.56	3.02	2.60	2.89	2.68	2.55
PB Ratio	1.66	1.93	1.72	2.18	1.90	1.78
P/TBV Ratio	4.33	5.03	7.73	28.90	-	4.38
P/FCF Ratio	10.03	11.66	14.30	16.56	12.40	9.84
P/OCF Ratio	9.98	11.61	14.23	16.51	12.20	9.58
PEG Ratio	-	0.53	0.53	0.53	0.53	0.53
EV/Sales Ratio	1.96	2.47	2.30	2.77	1.95	1.96
EV/EBITDA Ratio	9.15	11.51	14.23	14.10	10.06	5.26
EV/EBIT Ratio	21.15	26.59	104.31	40.53	14.18	5.80
EV/FCF Ratio	7.58	9.53	12.65	15.88	9.01	7.56
Debt / Equity Ratio	0.03	0.03	0.05	0.51	0.54	0.59
Debt / EBITDA Ratio	0.22	0.22	0.37	3.13	3.55	2.17
Debt / FCF Ratio	0.20	0.20	0.38	3.87	3.52	3.24
Asset Turnover	0.50	0.50	0.41	0.39	0.36	0.39
Inventory Turnover	1.18	1.18	0.99	0.98	1.12	1.40
Quick Ratio	2.04	2.04	1.38	0.91	1.55	2.30
Current Ratio	2.35	2.35	1.70	1.07	1.91	2.57
Return on Equity (ROE)	7.55%	7.55%	0.15%	7.13%	6.85%	18.94%
Return on Assets (ROA)	2.90%	2.90%	0.56%	1.68%	3.11%	8.24%
Return on Capital (ROIC)	3.77%	3.77%	0.73%	2.20%	4.08%	10.08%
Return on Capital Employed (ROCE)	5.70%	5.70%	1.40%	4.50%	5.80%	13.90%
Earnings Yield	430.23%	3.70%	0.08%	3.15%	3.45%	9.58%
FCF Yield	997.32%	8.58%	6.99%	6.04%	8.07%	10.16%
Buyback Yield / Dilution	-81.40%	-0.81%	10.01%	-13.47%	-1.24%	0.24%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q